China drug sector probe widens as Novo site visited

COPENHAGEN/LONDON (Reuters) – Chinese authorities have visited a site operated by Danish drugmaker Novo Nordisk A/S , the world’s biggest maker of insulin, the latest evidence of a widening investigation into Western drugmakers.

Powered by WPeMatico

This entry was posted in World News. Bookmark the permalink.

Comments are closed.